Glipizide
- Product NDC
- 51655-983
- 11-digit product format
- 516550983
- Labeler code
- 51655
- Product ID
- 51655-983_e04fcb8d-6453-5dc3-e053-2a95a90a8c39
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA206928
- Marketing category
- ANDA
- Marketing start
- 2022-05-04
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X7WDT95N5C | GLIPIZIDE | 29094-61-9 | GLIPIZIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-983-52 | 51655098352 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-983-52) | 2022-05-04 | 0000-00-00 | No | No | Current |